LEXICON PHARMACEUTICALS, INC. Secured Debt
LEXICON PHARMACEUTICALS, INC. (LXRX) had Secured Debt of $20.60 million as of 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:SecuredDebt · last filed 2014-11-06
- 2014-09-30: Secured Debt $20.60M.
- 2014-06-30: Secured Debt $21.00M.
- 2014-03-31: Secured Debt $21.50M.
- 2013-09-30: Secured Debt $22.30M.
| Period end | Secured Debt |
|---|---|
| 2014-09-30 | $20.60M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $21.00M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $21.50M 10-Q · filed 2014-05-08 |
| 2013-09-30 | $22.30M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $22.70M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $23.10M 10-Q · filed 2013-05-10 |
| 2012-09-30 | $23.80M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $24.20M 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |